Incidental histopathologic patterns: Possible evidence of 'field cancerization' surrounding skin tumors [1]

American Journal of Dermatopathology

Volumn 23, Issue 5, 2001, Pages 494-496

  Carlson, J A ^a   Scott, D ^a   Wharton, J ^a   Sell, S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOLYTIC DYSKERATOSIS; ADULT; AGE; CANCER LOCALIZATION; COMORBIDITY; CONTROLLED STUDY; HAILEY HAILEY DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; SUN EXPOSURE; THEORY;

ACANTHOLYSIS; HUMANS; KERATINOCYTES; KERATOSIS; MUTATION; SKIN; SKIN NEOPLASMS;

EID: 0034785560     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200110000-00020     Document Type: Letter

References (38)

1. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin
2. Second primary malignancies following diagnosis of small-cell lung cancer
3. Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England
4. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin
5. Incidence of invasive cancers following cutaneous malignant melanoma
6. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995
7. Second primary cancers in patients with squamous cell carcinoma of the skin: A population-based study in Sweden
8. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: A case-control study
9. Multiple primary melanomas: Analysis of 49 cases
10. Papillomavirus infections - A major cause of human cancers
11. Environmental factors in nonmelanoma and melanoma skin cancer
12. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation
13. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: Results from a case-control study
14. Loss of heterozygosity in human skin
15. Genetic and clinical mosaicism in a type of epidermal nevus
16. Human keratin diseases: Hereditary fragility of specific epithelial tissues
17. Type 2 segmental manifestation of Hailey-Hailey disease: Poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures
18. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump
19. Mosaicism for ATP2A2 mutations causes segmental Darier's disease
20. Spectrum of novel ATP2A2 mutations in patients with Darier's disease
21. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease
22. Incidental epidermolytic hyperkeratosis
23. Incidental focal acantholytic dyskeratosis
24. Hailey-Hailey-like pattern of acantholysis: A new histopathologic reaction pattern
25. Epidermolytic hyperkeratosis in nevi. A possible marker for atypia
26. Focal acantholytic dyskeratosis in experimental oral carcinogenesis in rats
27. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded nonneoplastic keratinocytes
28. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma
29. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population
30. Age distribution and histologic patterns of dysplastic nevi
31. Natural history of dysplastic nevi
32. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi
33. Mechanisms of tumor progression
34. Genetic instabilities in human cancers
35. Squamous cell carcinoma arising in Hailey-Hailey disease of the vulva
36. Darier's disease associated with cutaneous malignancies
37. Congenital epidermolytic hyperkeratosis associated with multiple malignancies
38. Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the World Health Organization Melanoma Programme